Literature DB >> 30959003

Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in Patients with Diabetic Macular Edema.

Mengyuan Fang1, Wenying Fan2, Yue Shi3, Michael S Ip3, Charles C Wykoff4, Kang Wang3, Khalil Ghasemi Falavarjani3, David M Brown4, Jano van Hemert5, SriniVas R Sadda6.   

Abstract

PURPOSE: To classify retinal nonperfusion regions (NPRs) in patients with diabetic macular edema (DME) and assess the relationship with severity of DME.
DESIGN: Prospective, observational case series.
METHODS: Forty eyes of 29 patients with treatment-naïve center-involved macular edema secondary to diabetes mellitus were included (The DAVE study, NCT01552408) in this analysis. Ultra-widefield fluorescein angiography (UWF FA) images were transmitted to the Doheny Image Reading Center, where they were corrected using stereographic projection to adjust for peripheral distortion. Two independent, certified graders manually evaluated the NPR and classified the nonperfusion as being associated with leakage or without leakage. The size of these 2 subtypes of NPR were computed in mm2 and assessed across the entire retina and within 3 concentric retinal zones. The relationship between subtype of NPR and the severity of DME was assessed.
RESULTS: In 40 eyes with treatment-naïve DME, visual acuity was significantly correlated with central macular thickness (CMT) and macular volume (MV). The NPR with leakage was positively correlated with CMT (R = 0.408, P = .009) and MV (R = 0.399, P = .011), whereas the NPR without leakage was negatively correlated with CMT (R = -0.468, P = .002) and MV (R = -0.473, P = .002). The NPR with leakage in the posterior region was significantly greater compared to the mid-periphery and the far periphery (P < .001), whereas the NPR without leakage was significantly greater in the mid-periphery compared with the far periphery or the posterior region (P = .001).
CONCLUSION: In patients with DME, the severity of DME appears to be positively correlated with NPR with leakage but negatively correlated with NPR without leakage. These findings may have implications for the pathophysiology of DME and the design of protocols for targeted laser in these eyes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30959003     DOI: 10.1016/j.ajo.2019.03.030

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Retinal non-perfusion in diabetic retinopathy.

Authors:  Charles C Wykoff; Hannah J Yu; Robert L Avery; Justis P Ehlers; Ramin Tadayoni; SriniVas R Sadda
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 3.775

2.  Clinical significance of metabolic quantification for retinal nonperfusion in diabetic retinopathy.

Authors:  Areum Jeong; Xue Yao; Jano van Hemert; Min Sagong
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

3.  Leakage index on ultra-widefield fluorescence angiography in different regions of retina and its correlation with cystoid macular edema in central retinal vein occlusion eyes.

Authors:  Xiaoling Wang; Gongpeng Sun; Zuohuizi Yi; A'min Xu; Lu He; Jingwen Jiang; Hongmei Zheng; Changzheng Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-24       Impact factor: 3.117

4.  Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.

Authors:  Natalia Figueiredo; Sunil K Srivastava; Rishi P Singh; Amy Babiuch; Sumit Sharma; Aleksandra Rachitskaya; Katherine Talcott; Jamie Reese; Ming Hu; Justis P Ehlers
Journal:  Ophthalmol Retina       Date:  2019-09-10

5.  Efficacy of intravitreal AFlibercept injection For Improvement of retinal Nonperfusion In diabeTic retinopathY (AFFINITY study).

Authors:  Yoon Jeon Kim; Joon Hyung Yeo; Gisung Son; Hyojoo Kang; Yu Sub Sung; Joo Yong Lee; June-Gone Kim; Young Hee Yoon
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10

6.  Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence.

Authors:  Bogumiła Sędziak-Marcinek; Sławomir Teper; Elżbieta Chełmecka; Adam Wylęgała; Mateusz Marcinek; Mateusz Bas; Edward Wylęgała
Journal:  J Diabetes Res       Date:  2021-02-26       Impact factor: 4.011

7.  Effects of refractive power on quantification using ultra-widefield retinal imaging.

Authors:  Su-Ho Lim; Seongyong Jeong; Jang Hwan Ahn; Jano van Hemert; Min Sagong
Journal:  BMC Ophthalmol       Date:  2021-03-20       Impact factor: 2.209

Review 8.  Current status and future possibilities of retinal imaging in diabetic retinopathy care applicable to low- and medium-income countries.

Authors:  Yamini Attiku; Ye He; Muneeswar Gupta Nittala; SriniVas R Sadda
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

9.  Differentiating features of OCT angiography in diabetic macular edema.

Authors:  Reza Mirshahi; Hamid Riazi-Esfahani; Elias Khalili Pour; Kaveh Fadakar; Parsa Yarmohamadi; Sayyed Amirpooya Alemzadeh; Samira Chaibakhsh; Khalil Ghasemi Falavarjani
Journal:  Sci Rep       Date:  2021-12-03       Impact factor: 4.379

Review 10.  Progress of Imaging in Diabetic Retinopathy-From the Past to the Present.

Authors:  Shintaro Horie; Kyoko Ohno-Matsui
Journal:  Diagnostics (Basel)       Date:  2022-07-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.